STOCK TITAN
  1. Home
  2. News
  3. PRTC

PureTech Health Plc - PRTC STOCK NEWS

IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq AKLI : Nasdaq
PureTech to Present at Two Upcoming Investor Conferences
conferences
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
clinical trial
IMPACT
SENTIMENT
PRTC : Nasdaq KRTX : Nasdaq
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
fda approval
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer
management
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Health: Notice of Half-Yearly Results
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders
clinical trial
IMPACT
SENTIMENT
PRTC : Nasdaq
Results of PureTech's Annual General Meeting
IMPACT
SENTIMENT
PRTC : Nasdaq
PureTech to Present at the Jefferies Healthcare Conference
conferences
Stock PRTC logo
PureTech Health Plc
Nasdaq:PRTC

PRTC Stock Data

Investment Advice
Finance and Insurance
Link

About PRTC

PureTech Health is a biotechnology company which develops medicines to combat serious diseases.